FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280492919> ?p ?o ?g. }

• W4280492919 endingPage "2484" @default.
• W4280492919 startingPage "2484" @default.
• W4280492919 abstract "This study aimed to refine combined targeted approaches on well-characterized, low-passage tumor models. Upon in vivo xenografting in immunodeficient mice, three cell lines from locally advanced or metastatic HNSCC were established. Following quality control and basic characterization, drug response was examined after therapy with 5-FU, Cisplatin, and cyclin-dependent kinase inhibitors (abemaciclib, THZ1). Our cell lines showed different in vitro growth kinetics, morphology, invasive potential, and radiosensitivity. All cell lines were sensitive to 5-FU, Cisplatin, and THZ1. One cell line (HNSCC48 P0 M1) was sensitive to abemaciclib. Here, Cyto-FISH revealed a partial CDKN2a deletion, which resulted from a R58* mutation. Moreover, this cell line demonstrated chromosome 12 polysomy, accompanied by an increase in CDK4-specific copy numbers. In HNSCC16 P1 M1, we likewise identified polysomy-associated CDK4-gains. Although not sensitive to abemaciclib per se, the cell line showed a G1-arrest, an increased number of acidic organelles, and a swollen structure. Notably, intrinsic resistance was conquered by Cisplatin because of cMYC and IDO-1 downregulation. Additionally, this Cisplatin-CDKI combination induced HLA-ABC and PD-L1 upregulation, which may enhance immunogenicity. Performing functional and molecular analysis on patient-individual HNSCC-models, we identified CDK4-gains as a biomarker for abemaciclib response prediction and describe an approach to conquer intrinsic CDKI resistance." @default.
• W4280492919 created "2022-05-22" @default.
• W4280492919 creator A5012794413 @default.
• W4280492919 creator A5037315050 @default.
• W4280492919 creator A5053164549 @default.
• W4280492919 creator A5055468693 @default.
• W4280492919 creator A5058541632 @default.
• W4280492919 creator A5059713125 @default.
• W4280492919 creator A5064242864 @default.
• W4280492919 creator A5070417544 @default.
• W4280492919 creator A5071273133 @default.
• W4280492919 creator A5077750770 @default.
• W4280492919 creator A5086019788 @default.
• W4280492919 creator A5087351196 @default.
• W4280492919 creator A5088697397 @default.
• W4280492919 date "2022-05-18" @default.
• W4280492919 modified "2023-09-26" @default.
• W4280492919 title "Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches" @default.
• W4280492919 cites W1550884756 @default.
• W4280492919 cites W2021350067 @default.
• W4280492919 cites W2055843917 @default.
• W4280492919 cites W2095808484 @default.
• W4280492919 cites W2108836663 @default.
• W4280492919 cites W2150575159 @default.
• W4280492919 cites W2160292051 @default.
• W4280492919 cites W2275816640 @default.
• W4280492919 cites W2279024304 @default.
• W4280492919 cites W2347431815 @default.
• W4280492919 cites W2498866376 @default.
• W4280492919 cites W2761928743 @default.
• W4280492919 cites W2763353353 @default.
• W4280492919 cites W2765178540 @default.
• W4280492919 cites W2769376007 @default.
• W4280492919 cites W2792040629 @default.
• W4280492919 cites W2891507326 @default.
• W4280492919 cites W2899066274 @default.
• W4280492919 cites W2932330869 @default.
• W4280492919 cites W2938964227 @default.
• W4280492919 cites W2948287839 @default.
• W4280492919 cites W2969426297 @default.
• W4280492919 cites W2970349558 @default.
• W4280492919 cites W3003058371 @default.
• W4280492919 cites W3005765925 @default.
• W4280492919 cites W3011865075 @default.
• W4280492919 cites W3015838068 @default.
• W4280492919 cites W3016741234 @default.
• W4280492919 cites W3026268073 @default.
• W4280492919 cites W3030448313 @default.
• W4280492919 cites W3045332222 @default.
• W4280492919 cites W3049314385 @default.
• W4280492919 cites W3082990138 @default.
• W4280492919 cites W3107251721 @default.
• W4280492919 cites W3122988797 @default.
• W4280492919 cites W3128501601 @default.
• W4280492919 cites W3136419328 @default.
• W4280492919 cites W3161558405 @default.
• W4280492919 cites W3190352263 @default.
• W4280492919 cites W4211145083 @default.
• W4280492919 cites W3168705083 @default.
• W4280492919 doi "https://doi.org/10.3390/cancers14102484" @default.
• W4280492919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35626088" @default.
• W4280492919 hasPublicationYear "2022" @default.
• W4280492919 type Work @default.
• W4280492919 citedByCount "0" @default.
• W4280492919 crossrefType "journal-article" @default.
• W4280492919 hasAuthorship W4280492919A5012794413 @default.
• W4280492919 hasAuthorship W4280492919A5037315050 @default.
• W4280492919 hasAuthorship W4280492919A5053164549 @default.
• W4280492919 hasAuthorship W4280492919A5055468693 @default.
• W4280492919 hasAuthorship W4280492919A5058541632 @default.
• W4280492919 hasAuthorship W4280492919A5059713125 @default.
• W4280492919 hasAuthorship W4280492919A5064242864 @default.
• W4280492919 hasAuthorship W4280492919A5070417544 @default.
• W4280492919 hasAuthorship W4280492919A5071273133 @default.
• W4280492919 hasAuthorship W4280492919A5077750770 @default.
• W4280492919 hasAuthorship W4280492919A5086019788 @default.
• W4280492919 hasAuthorship W4280492919A5087351196 @default.
• W4280492919 hasAuthorship W4280492919A5088697397 @default.
• W4280492919 hasBestOaLocation W42804929191 @default.
• W4280492919 hasConcept C104317684 @default.
• W4280492919 hasConcept C121608353 @default.
• W4280492919 hasConcept C126322002 @default.
• W4280492919 hasConcept C127561419 @default.
• W4280492919 hasConcept C2776530083 @default.
• W4280492919 hasConcept C2776694085 @default.
• W4280492919 hasConcept C2776833033 @default.
• W4280492919 hasConcept C2777542201 @default.
• W4280492919 hasConcept C2778239845 @default.
• W4280492919 hasConcept C2781303241 @default.
• W4280492919 hasConcept C30481170 @default.
• W4280492919 hasConcept C502942594 @default.
• W4280492919 hasConcept C54355233 @default.
• W4280492919 hasConcept C71924100 @default.
• W4280492919 hasConcept C81885089 @default.
• W4280492919 hasConcept C86803240 @default.
• W4280492919 hasConceptScore W4280492919C104317684 @default.
• W4280492919 hasConceptScore W4280492919C121608353 @default.
• W4280492919 hasConceptScore W4280492919C126322002 @default.

• next